Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Follitropin delta plus menotropin for predicted poor ovarian responders undergoing IVF
RBR-2kmyfmPhase 4Not yet recruiting
- Sponsor
- Vidabemvinda
- Start
- Mar 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of follitropin delta and menotropins in infertility (2 arms), sponsored by Vidabemvinda. Planned start Mar 2020; status: not yet recruiting.
02
Drugs
follitropin deltamenotropins
03
Conditions
infertility
Beyond the preview
Go deeper on RBR-2kmyfm.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-2kmyfm.